Reproductive Medicine Center, Zhongnan Hospital of Wuhan University, 169 DongHu Rd, Wuhan, 430071, China,
J Assist Reprod Genet. 2013 Sep;30(9):1161-7. doi: 10.1007/s10815-013-0057-3. Epub 2013 Aug 2.
To explore the prevalence and risk factors for depression in men undergoing different assisted reproductive technique (ART) treatments in Chinese population.
This was a prospective study of 844 men undergoing ART treatments. All men were distributed to four groups, according to they received treatments. The treatments included IUI (intrauterine insemination), IVF(in vitro fertilization), ICSI(intra cytoplasmatic sperm injection) and TESA/PESA (percutaneous epididymal sperm aspiration/testicular sperm aspiration). Their symptoms of depression were measured with use of the Center for Epidemiologic Studies of Depression scale(CES-D). Data were collected about age, BMI, education, duration of marriage, duration of infertility, smoking, type of infertility, infertility causes, history of ejaculation failure, and financial burden of the treatment. We estimated the prevalence of depressive symptom in men undergoing different ART and used logistic regression models to identify risk factors for depression in different groups.
The overall prevalence of depression was 13.3 % for men undergoing ART treatments: 14.5 % of IUI group, 12.4 % of IVF group, 19.2 % of ICSI group and 6.2 % of TESA/PESA group. Prevalence of depression among IUI group, IVF group and ICSI group were not significantly different. For IUI group, the factors were found to increase depression risk were treatment financial burden and duration of marriage, to decrease depression risk was age. For IVF group, the risk factors independently associated with depression were both male and female infertility, unexplained infertility, and history of ejaculation failure.
In a sample of Chinese men undergoing ART treatments, the prevalence of depression was higher than other country. The risk factors for depression varied in different ART treatments groups. when routine screening to identify the sub-group of vulnerable men which need counselling before ART treatments, we should also consider which pattern of ART treatments the man underwent.
探讨中国男性接受不同辅助生殖技术(ART)治疗时抑郁的患病率和相关危险因素。
这是一项对 844 名接受 ART 治疗的男性进行的前瞻性研究。所有男性根据接受的治疗分为四组。治疗方法包括 IUI(宫腔内人工授精)、IVF(体外受精)、ICSI(卵胞浆内单精子注射)和 TESA/PESA(经皮附睾精子抽吸/睾丸精子抽吸)。采用抑郁自评量表(CES-D)评估他们的抑郁症状。收集的资料包括年龄、BMI、教育程度、婚姻持续时间、不孕持续时间、吸烟、不孕类型、不孕原因、射精失败史和治疗的经济负担。我们估计了男性接受不同 ART 治疗时出现抑郁症状的患病率,并采用 logistic 回归模型确定不同组中抑郁的危险因素。
接受 ART 治疗的男性中抑郁的总体患病率为 13.3%:IUI 组为 14.5%,IVF 组为 12.4%,ICSI 组为 19.2%,TESA/PESA 组为 6.2%。IUI 组、IVF 组和 ICSI 组的抑郁患病率无显著差异。对于 IUI 组,发现增加抑郁风险的因素是治疗经济负担和婚姻持续时间,降低抑郁风险的因素是年龄。对于 IVF 组,与抑郁独立相关的危险因素是男性和女性不孕、不明原因不孕和射精失败史。
在中国接受 ART 治疗的男性样本中,抑郁的患病率高于其他国家。不同 ART 治疗组中抑郁的危险因素不同。在常规筛查以确定需要在 ART 治疗前进行咨询的易受影响的男性亚组时,我们还应考虑男性接受的 ART 治疗模式。